These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 34551181)

  • 1. Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients.
    Kantauskaite M; Müller L; Kolb T; Fischer S; Hillebrandt J; Ivens K; Andree M; Luedde T; Orth HM; Adams O; Schaal H; Schmidt C; Königshausen E; Rump LC; Timm J; Stegbauer J
    Am J Transplant; 2022 Feb; 22(2):634-639. PubMed ID: 34551181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response to third SARS-CoV-2 vaccination in seronegative kidney transplant recipients: Possible improvement by mycophenolate mofetil reduction.
    Kantauskaite M; Müller L; Hillebrandt J; Lamberti J; Fischer S; Kolb T; Ivens K; Koch M; Andree M; Lübke N; Schmitz M; Luedde T; Orth HM; Feldt T; Schaal H; Adams O; Schmidt C; Kittel M; Königshausen E; Rump LC; Timm J; Stegbauer J
    Clin Transplant; 2022 Nov; 36(11):e14790. PubMed ID: 35997031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients and in Kidney Transplant Recipients.
    Kolb T; Fischer S; Müller L; Lübke N; Hillebrandt J; Andrée M; Schmitz M; Schmidt C; Küçükköylü S; Koster L; Kittel M; Weiland L; Dreyling KW; Hetzel G; Adams O; Schaal H; Ivens K; Rump LC; Timm J; Stegbauer J
    Kidney360; 2021 Sep; 2(9):1491-1498. PubMed ID: 35373105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.
    Kho MML; Messchendorp AL; Frölke SC; Imhof C; Koomen VJ; Malahe SRK; Vart P; Geers D; de Vries RD; GeurtsvanKessel CH; Baan CC; van der Molen RG; Diavatopoulos DA; Remmerswaal EBM; van Baarle D; van Binnendijk R; den Hartog G; de Vries APJ; Gansevoort RT; Bemelman FJ; Reinders MEJ; Sanders JF; Hilbrands LB;
    Lancet Infect Dis; 2023 Mar; 23(3):307-319. PubMed ID: 36354032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response to non-mRNA SARS-CoV-2 vaccine in kidney transplant recipients.
    Bajpai D; Bose S; Saxena N; Kulkarni B; Kumar K; Rao N; Thakare S; Torane V; Nataraj G; Jamale T
    Vaccine; 2024 Nov; 42(25):126206. PubMed ID: 39122634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients.
    Toniutto P; Falleti E; Cmet S; Cussigh A; Veneto L; Bitetto D; Fornasiere E; Fumolo E; Fabris C; Sartor A; Peressutti R; Curcio F; Regattin L; Grillone L
    J Hepatol; 2022 Jul; 77(1):152-162. PubMed ID: 35283215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolic Acid Exposure Determines Antibody Formation Following SARS-CoV-2 Vaccination in Kidney Transplant Recipients: A Nested Cohort Study.
    Meziyerh S; Bouwmans P; van Gelder T; van der Helm D; Messchendorp L; van der Boog PJM; de Fijter JW; Moes DJAR; de Vries APJ;
    Clin Pharmacol Ther; 2023 Jul; 114(1):118-126. PubMed ID: 36789469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Response to COVID-19 mRNA Vaccination in Previous Nonresponder Kidney Transplant Recipients After Short-term Withdrawal of Mycophenolic Acid 1 and 3 Months After an Additional Vaccine Dose.
    Kühn T; Speer C; Morath C; Bartenschlager M; Kim H; Beimler J; Buylaert M; Nusshag C; Kälble F; Reineke M; Töllner M; Klein K; Blank A; Parthé S; Schnitzler P; Zeier M; Süsal C; Bartenschlager R; Tran TH; Schaier M; Benning L
    Transplantation; 2023 May; 107(5):1139-1150. PubMed ID: 36617671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Drug Monitoring of Mycophenolic Acid Identifies Kidney Transplant Recipients Responsive to Two SARS-CoV-2 mRNA Vaccine Doses.
    von Moos S; Rho E; Dammann M; Kokkonen SM; Mueller TF; Schachtner T
    Transpl Int; 2023; 36():11286. PubMed ID: 37448450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children.
    Gulmez R; Ozbey D; Agbas A; Aksu B; Yildiz N; Uckardes D; Saygili S; Yilmaz EK; Yildirim ZY; Tasdemir M; Kiykim A; Cokugras H; Canpolat N; Nayir A; Kocazeybek B; Caliskan S
    Pediatr Nephrol; 2023 Jul; 38(7):2199-2208. PubMed ID: 36459243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing SARS-CoV-2 vaccine responses in kidney transplant recipients: an urgent need.
    Cheng Y-L; Chang S-S; Chao C-H; Chen P-T; Lin Y-L; Syu G-D; Lee N-Y; Chen P-L; Ko W-C; Ho T-S
    Microbiol Spectr; 2024 Jun; 12(6):e0000424. PubMed ID: 38747636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Humoral Immune Response After COVID-19 Vaccination in Elderly Kidney Transplant Recipients on Everolimus Versus Mycophenolate Mofetil-containing Immunosuppressive Regimens.
    de Boer SE; Berger SP; van Leer-Buter CC; Kroesen BJ; van Baarle D; Sanders JF;
    Transplantation; 2022 Aug; 106(8):1615-1621. PubMed ID: 35546527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood unconjugated bilirubin and tacrolimus are negative predictors of specific cellular immunity in kidney transplant recipients after SAR-CoV-2 inactivated vaccination.
    Zhang L; Yang J; Deng M; Xu C; Lai C; Deng X; Wang Y; Zhou Q; Liu Y; Wan L; Li P; Fang J; Hou J; Lai X; Ma F; Li N; Li G; Kong W; Zhang W; Li J; Cao M; Feng L; Chen Z; Chen L; Ji T
    Sci Rep; 2023 May; 13(1):7263. PubMed ID: 37142713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of Immune Response to Anti-SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients: A Prospective Cohort Study.
    Magicova M; Zahradka I; Fialova M; Neskudla T; Gurka J; Modos I; Hojny M; Raska P; Smejkal P; Striz I; Viklicky O
    Transplantation; 2022 Apr; 106(4):842-852. PubMed ID: 34999659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: a controlled trial.
    Keshtkar-Jahromi M; Argani H; Rahnavardi M; Mirchi E; Atabak S; Tara SA; Gachkar L; Noori-Froothghe A; Mokhtari-Azad T
    Am J Nephrol; 2008; 28(4):654-60. PubMed ID: 18322360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
    Reindl-Schwaighofer R; Heinzel A; Mayrdorfer M; Jabbour R; Hofbauer TM; Merrelaar A; Eder M; Regele F; Doberer K; Spechtl P; Aschauer C; Koblischke M; Paschen C; Eskandary F; Hu K; Öhler B; Bhandal A; Kleibenböck S; Jagoditsch RI; Reiskopf B; Heger F; Bond G; Böhmig GA; Strassl R; Weseslindtner L; Indra A; Aberle JH; Binder M; Oberbauer R
    JAMA Intern Med; 2022 Feb; 182(2):165-171. PubMed ID: 34928302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent SARS-CoV-2-specific immune defects in kidney transplant recipients following third mRNA vaccine dose.
    Werbel WA; Karaba AH; Chiang TP; Massie AB; Brown DM; Watson N; Chahoud M; Thompson EA; Johnson AC; Avery RK; Cochran WV; Warren D; Liang T; Fribourg M; Huerta C; Samaha H; Klein SL; Bettinotti MP; Clarke WA; Sitaras I; Rouphael N; Cox AL; Bailey JR; Pekosz A; Tobian AAR; Durand CM; Bridges ND; Larsen CP; Heeger PS; Segev DL;
    Am J Transplant; 2023 Jun; 23(6):744-758. PubMed ID: 36966905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil decreases humoral responses to three doses of SARS-CoV-2 vaccine in liver transplant recipients.
    Meunier L; Sanavio M; Dumortier J; Meszaros M; Faure S; Ursic Bedoya J; Echenne M; Boillot O; Debourdeau A; Pageaux GP
    Liver Int; 2022 Aug; 42(8):1872-1878. PubMed ID: 35338550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination.
    De Bouver C; Bouziotis J; Wijtvliet VPWM; Ariën KK; Mariën J; Heyndrickx L; Couttenye MM; de Fijter HJW; Mestrez F; Treille S; Mat O; Collart F; Allard SD; Vingerhoets L; Moons P; Abramowicz D; De Winter BY; Pipeleers L; Wissing KM; Ledeganck KJ
    Virol J; 2024 Jun; 21(1):138. PubMed ID: 38872127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated With Vaccine-Induced T-Cell Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 in Kidney Transplant Recipients.
    Tometten I; Landmann S; Kantauskaite M; Lamberti J; Hillebrandt J; Müller L; Kittel M; Kolb T; Ivens K; Schmitz M; Voges A; Adams O; Andrée M; Schaal H; Lübke N; Königshausen E; Rump LC; Stegbauer J; Timm J
    J Infect Dis; 2023 Mar; 227(5):641-650. PubMed ID: 36408631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.